Vitamin D has a selective radio and chemosensitizing effect on tumor cells. In vitro and in vivo studies have shown that vitamin D inhibits collagen gel construction, induces type II pneumocyte proliferation and surfactant synthesis in the lungs, and decreases vascular permeability caused by radiation. The aim of this experimental study was to determine if vitamin D has a protective effect against radiation-induced pulmonary damage. Adult Wistar rats were divided into 4 groups. Group 1 was comprised of control animals. Group 2, which was administered 0.25 μg/kg/day of vitamin D3 for 8 weeks, was the vitamin D control group. Rats in groups 3 and 4 were given 20 Gy right hemithorax radiotherapy, and in addition group 4 was given vitamin D3 treatment, which began the day before the radiotherapy and continued for 8 weeks. At the 8 th and the 12 th weeks of the study 4 rats from each group were sacrificed. Right lungs were dissected for light and electron microscopic study. The electron microscopy examinations revealed statistically significant differences between group 3 and 4, and in group 4 there was less interstitial inflammation and collagen deposition, and the alveolar structure and the cells lining the alveolar walls were protected. These results confirm that vitamin D has a protective effect against radiation-induced pulmonary toxicity. These findings should be evaluated with further clinical studies.
INTRODUCTION
It has been shown that damage to different cells and the interaction between those cells and others leads to radiation pneumonitis. [1] [2] [3] Fibrosis, on the other hand, is a complicated tissue response, which is characterized by the accumulation of extracellular matrix proteins and proliferation of fibroblasts. Myofibroblasts proliferate and synthesize collagen matrix proteins. Negative feed back mechanisms control cell activity and the differentiated myofibroblasts die by apoptosis. In the formation of fibrosis the negative feed back mechanisms that control the myofibroblasts are not activated. 4) The antineoplastic activity of vitamin D was first demonstrated in mouse myeloid leukemia cells. 5) In vitro and in vivo studies have demonstrated vitamin D's inhibitory effect on the growth of breast, colon, prostate, endometrial, bladder, and pancreatic cancers, and osteosarcoma cell lines. [6] [7] [8] [9] It has also been demonstrated that vitamin D has a selective radiosensitizing effect on cancer cells, without any such effect on fibroblasts. 7, 10) Platelet-derived growth factor (PDGF) is synthesized by thrombocytes and macrophages, and is a chemotactic agent for neutrophils, monocytes, and fibroblasts, as well as a growth factor for fibroblasts. PDGF plays a major role in pulmonary fibrosis. It has been reported that vitamin D inhibits DNA synthesis in fibroblasts, which is activated by PDGF. [11] [12] [13] [14] On the other hand, vitamin D inhibits the transformation of fibroblasts into myofibroblasts, which is induced by TGFβ-1. 12) Moreover, vitamin D has been shown to inhibit the proliferation of fibroblasts in skin. 13) In the treatment of myelofibrosis, a disease characterized by over production of collagen in bone marrow, vitamin D was reported to be effective. 14) Furthermore, in the treatment of aggressive fibromatosis, a disease characterized by monoclonal fibroblast proliferation and collagen deposition, the administration of vitamin D reduced the size of masses that were resistant to surgery, radiotherapy, and tamoxifen. 15) The lungs are the major dose-limiting structures in thoracic irradiation. In different studies symptomatic radiation pneumonitis was observed in 1%-34% of patients; however, radiological changes were observed in 13%-100% of patients. [16] [17] [18] [19] [20] As the criteria used to define radiation pneumonitis and the volume of the lung that is irradiated varies, it is not possible to compare studies. The proposed mechanisms of radiation pneumonitis and fibrosis are: Damage caused to type II pneumocytes and the release of surfactant into the alveolar space; increased vascular permeability due to endothelial cell damage; the release of cytokines and growth factors, which activate molecular mechanisms that cause fibrosis. [1] [2] [3] [21] [22] [23] [24] The aim of the present experimental study was to determine if vitamin D has a protective effect against radiation-induced pulmonary damage. Right lung of rats were irradiated with a single dose of 20 Gy via 6 MV photons, and the effect of prophylactic vitamin D treatment on radiation-induced pneumonitis and fibrosis was evaluated by light and electron microscopy studies.
MATERIALS AND METHODS

Animals
The study included 32 adult male Wistar rats (200-250 g), the use of which was approved by the Hacettepe University Animal Care and Use Committee. Rats were obtained from the Hacettepe University Experimental Animal Laboratory. Animals were housed 4 per cage in a controlled animal holding room with a 12/12-h light/dark cycle; temperature and relative humidity were continually monitored to provide standard laboratory conditions. Food and water were provided ad libitum. The animals were randomly assigned to 4 groups: Group 1, sham irradiation; group 2, vitamin D3; group 3, radiotherapy; group 4, radiotherapy + vitamin D3.
Irradiation
Before irradiation rats were anesthetized using pentobarbital (60 mg/kg) administered intraperitoneally. The animals were stabilized in the prone position and the right hemithorax of each rat was defined by simulation. The rats were given a single 20-Gy dose with 6 MV photons (Philips SL 25 linear accelerator) to the whole right hemithorax using the SAD (source-axis distance) technique. 11, 18) Irradiation was performed in one direction, from anterior to posterior, and the depth was calculated from the midline. To provide contour regularity, 1-cm elasto-gel bolus was used. The left thorax and the rest of the body were shielded with a lead block. All procedures, except irradiation, were also performed on the control groups.
Drug
For the drug groups (groups 2 and 4) 0.25 μg/kg/day of vitamin D3 (Calcijex, Abbott Laboratories, North Chicago, USA) was administered subcutaneously. 25) The administration of vitamin D3 began 1 day before radiotherapy and continued for 8 weeks. An equal amount of 0.9% NaCl was subcutaneously administered to groups 1 and 3 every day for the 8 weeks.
Morphologic studies
At the 8 th and 12 th weeks of the study 4 animals from each group were sacrificed for morphological examination. The animals were killed by intraperitoneal high-dose pentobarbital injection, and both lungs were removed from the chests of the animals.
Light microscopy
The lungs were fixed in 10% formaldehyde solution and embedded in paraffin for light microscobic examination after punch biopsies were taken from each right lung for evaluation with electron microscopy. The slices obtained were stained with hematoxylin and eosin (H&E), Massontrichrome, and toluidine blue. Masson-trichrome stain was used to examine fibrosis, toluidine blue was used to count mast cells, and hyaline membrane formation, macrophage infiltration, and interstitial inflammation were evaluated with H&E. Perivascular and interstitial mast cell counts were evaluated at 10× magnification. Interstitial inflammation, fibrosis, hyaline membrane formation, and macrophage infiltration were evaluated with a semi-quantitative technique and were scored as 0-3. The examinations and the grading were performed by the same pathologist blinded to the treatment groups.
Electron microscopy
Punch biopsies were fixed in 2.5% glutaraldehyde solution in a phosphate tampon of pH 7.4. After 24 h of fixation they were washed with Sorenson's phosphate buffer (SPB). Post-fixation was applied by washing with 1.0% osmium tetroxide solution for 1 h. The samples were dehydrated by passing them through an ethanol series. Following dehydration they were treated with propylene oxide and then blocked with Araldite CY 212. Slices (1-2 μm thick) were stained with toluidine blue-Azur II. Electron microscopy examinations were conducted and 60-90-nm thick slices were taken from chosen fields with a Leica UltracutR (Vienna, Austria) ultramicrotome. Thin slices were contrasted with uranyl acetate and lead citrate, and then were examined under a Leo 906E (80 kV) (Oberkohen, Germany) transmission electron microscope. To score the electron microscopic findings thin sections from each group were examined and various pulmonary radiation damage indicators like neutrophils, edema, extravascular erythrocytes, fibroblasts, collagen bundles, macrophages, mast cells, eosinophils and debris collections were counted at 20 areas with 5000 magnification.
STATISTICAL METHODS
The Statistical Package for Social Sciences (SPSS) v.11.0 was used for statistical analyses. As the histological scores were ordinal in nature, the differences in histological findings between the 4 study groups were analyzed using the Kruskal-Wallis test. When an overall statistically significant difference was observed, pairwise comparisons were performed using the Mann-Whitney U test, with a correction for multiple comparisons. A 5% type-I error level was used for the statistical significance cut-off for overall comparisons. The differences between the electron microscobic scoring for groups with and without vitamin D and weeks 8 and 12 were compared using the Mann-Whitney U test. The overall comparisons for groups were also performed using the Kruskal-Wallis test.
RESULTS
Light microscopy findings
Light microscopy examinations revealed no differences in fibrosis scores between the groups. Statistically significant differences in interstitial inflammation, edema, bleeding, macrophage infiltration, interstitial mast cell count, and perivascular mast cell count were observed between groups 3 and 4, and groups 1 and 2; however, no differences were observed between groups 3 and 4 ( Table 1) .
Electron microscopic findings
The eight week electron microscobic examinations revealed statistically significant differences in edema, extravascular erytrocytes, fibroblasts, collageen bundles, macrophages, mast cells, eosinophills, and debris collection between groups 3 and 4. The differences between the groups for extravascular erytrocytes, collageen bundles, macrophages, mast cells, eosinophills and debris collection were still statistically significant at the twelfth week evaluations. The overall comparisons showed statistically significant differences for all the pulmonary radiation damage indicators but the macrophage count ( Table 2) .
The eighth-week evaluation of the rats in group 3 showed that there was an increase in mast cells and eosinophils in the perivascular space, and that the epithelial cells that lined the alveoli were damaged and desquamated. Serous fluid accumulation and bleeding were observed in the alveolar space, and the alveolar space was narrowed. Accumulation of connective tissue and collagen bundles, cell infiltration, and an increase in the number of fibrocytes were the principal findings observed in the interstitial field (Fig. 1A-B) .
The eighth-week examination of the rats in group 4 revealed that there were no exudates or bleeding in the alve- olar sacs, and the cells that line the alveolar walls had not degenerated and were healthier than those in group 3 rats. In contrast to group 3, there was less cell infiltration in the interstitial field among the group 4 rats. There was a distinct decrease in the number of mast cells and eosinophils in group 4; however, there were more macrophages. Collagen fibers were observed in the interstitial field of group 4 rats, but again, when compared to group 3 the amount was clearly less, and the collagen fibers were not organized (Fig. 1C-D) . Twelfth-week evaluation findings were similar to the eighth-week findings. Dense inflammation, collagen fiber accumulation, and organization of the fibers into large bundles continued in group 3. Fibrosis was observed to increase in the interstitial field, serous fluid accumulation continued in the alveolar lumen, and the cells that line the alveolar wall were degenerated ( Fig. 2A-B) .
In group 4, twelfth-week findings showed that alveolar lumens were vacant, cells that lined the alveolar walls were healthy, and there was no bleeding in alveolar lumens. In the interstitial space neither collagen fibers nor signs of inflammation were observed. In contrast to group 3, fibrosis was not observed in group 4 ( Fig. 2C-D) .
DISCUSSION
Previously, it was believed that radiotherapy decreases the number of pulmonary parenchymal cells or vessel cells, which results in pulmonary damage, and that this damage is neither preventable nor treatable. However, studies performed in the past few years showed that late tissue damage is a result of a dynamic process in which normal cells actively play a role, and that the interaction between different cell groups results in fibrosis. 4, 26) The hypothesis that radiationinduced pulmonary fibrosis might be prevented by treating the cellular dysfunction of parenchymal or vascular cells, which is observed in chronic inflammation, or by avoiding the chronic increase observed in specific cytokines and growth factors was the starting point for the present, as it was for many other studies. In the present study the effect of vitamin D3 in preventing radiation-induced pulmonary toxicity in rats given a single dose of 20-Gy radiotherapy was examined. Light microscopy revealed no significant dif- ference between the irradiation only (group 3) and irradiation + vitamin D (group 4) groups; however, electron microscopy findings showed that the signs of radiationinduced pulmonary toxicity were significantly less severe in group that received irradiation + vitamin D.
The first study to examine the role of vitamin D in preventing radiation-induced pulmonary toxicity was performed by Graham et al. 11) They proposed that the mechanisms involved in radiation-induced pulmonary toxicity might be similar to those involved in idiopathic pulmonary fibrosis, and they treated rats given pulmonary radiotherapy with vitamin D, dexamethasone, and indomethacin, separately. They reported that in the rats given 18-Gy left hemithorax radiotherapy, vascular permeability increased significantly in the third week, and that dexamethasone, vitamin D, and indomethacin prevented radiation-induced vascular permeability. 11) In our study light microscopy findings revealed no differences between the groups at any time point; however, electron microscopic evaluations showed that vitamin D reduced the damage in type II pneumocytes, reduced interstitial inflammation, collagen bundle deposition, and fibrosis, and prevented the narrowing of the alveolar space and deposition of exudates in the alveolar space. The decrease in the inflammatory cell accumulation in the perivascular space in response to vitamin D, which is a sign of a decrease in vascular permeability, is consistent with Graham et al. 11) It was reported that the effect of radiotherapy on type II pneumocytes could be observed in the first 24 h with electron microscopy and that fibrotic changes occured in the following 1-3 months. 19) In the present study fibrotic changes were apparent in the eighth week. In the group that received irradiation alone increased eosinophil and mast cell accumulation in the perivascular field, destruction of epithelial cells that line the alveoli and shedding of those cells to the alveolar space, serous fluid accumulation and bleeding in the alveolar space, connective tissue accumulation, increased cell infiltration and fibrocytes, accumulation of collagen bundles in the interstitial space, and narrowing of the alveolar space was observed. In irradiation + vitamin D group it was observed that the cells that line the alveoli were not destroyed, there was no narrowing of the alveolar space, and no debris or accumulation of exudates was observed in the alveolar space. The cells were not degenerated and were healthier when compared to irradiation only group. We also observed a significant decrease in inflammatory cell and collagen bundle accumulation in the interstitial space. Vitamin D injections were stopped after 8 weeks; however, at the twelfth week the protective effect of vitamin D could still be observed. At the twelfth week it was observed in irradiation only group that inflammatory cell accumulation continued, collagen bundles were organized, and fibrosis was observed in the interstitial space. In irradiation + vitamin D group however, cell degeneration, interstitial inflammation, and collagen accumulation or fibrosis were not prominent. The cells and the ultra structure of the lungs were healthier when compared to irradiation only group; however, no apparent difference between the groups could be found with light microscopy evaluation. This discrepancy between the light and electron microscopy findings may have been a result of the grading system that was used for light microscopy. The grading system of 0-3 may not have been enough to detect small differences. Generally, studies based on light microscopy reported that fibrotic changes could be observed after 6 months, though there are studies in the literature that reported observing fibrosis 12 weeks after radiotherapy. 27) In our study all the rats were sacrificed and examined 12 weeks after radiotherapy. We think that it might have been possible to detect differences between groups that received irradiation alone and irradiation + vitamin D with light microscopy had we waited longer.
Vitamin D has antineoplastic effects against several cancer types. 6, 7, 9) Besides its antineoplastic effect it also increases the radiosensitivity of the cancer cells by inducing apoptosis, inhibiting the progression of the cell through the cell cycle and causing cell arrest at G1/S and G2/M phases (radiosensitive phases), inhibiting cell proliferation, and inducing the differentiation of the cells. 7, 10, [28] [29] [30] The radiosensitizer effect of vitamin D is selective. It has no such effect on normal fibroblasts and keratinocytes. 10, 31) . In kidneys vitamin D inhibits the transformation of fibroblasts to myofibroblasts which is induced by TGFβ-1. 12) In skin it inhibits the proliferation of fibroblasts.
13) The clinic observation of reduction in the size of an agressive fibromatosis mass resistant to surgery, radiotherapy, and tamoxifen under vitamin D treatment caused a speculation that vitamin D may have a role in the degradation of collagen. 15, 32) To evaluate the molecular mechanims of vitamin D's anticancer, selective radiosensitizer, and antifibrotic effects is beyond the aim of this study. However a radioprotector which also has antineoplastic effects is an appealing treatment modality for radiation oncologists and can be used to increase the therapeutic ratio in the treatment of various tumor types. We suggest, whether vitamin D fits in this category should be evaluated with further studies.
In conclusion, the present study revealed that vitamin D may have a potential beneficial effect in the prevention of radiation-induced pneumonitis and pulmonary fibrosis. We recommend that clinical studies be conducted to confirm these experimental findings.
